Liza Amlani (31:37) We will
A review of pivotal clinical trials for semaglutide (STEP, SUSTAIN), dulaglutide (REWIND), liraglutide (LEADER), and tirzepatide (SURPASS, SURMOUNT) does not identify muscle cramps as occurring at significantly higher rates compared to placebo groups
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al
Long-term wellness, bone strength, and ongoing anti-aging benefits may continue with appropriate cycling and monitoring
When it comes to this new product development, Carolina Villamizar, health and nutrition scientific director at Alianza, said shes seeing more companies renovate existing products to appeal to these consumers rather than develop new ones
The outcomes of this study should be used with caution if patients have co-morbidities that may affect efficacy